Kohli Prashant 4
4 · Acasti Pharma Inc. · Filed Jul 18, 2023
Insider Transaction Report
Form 4
Kohli Prashant
DirectorChief Executive Officer
Transactions
- Award
Stock Options (Right to Buy)
2023-07-14+208,334→ 208,334 totalExercise: $2.64Exp: 2033-07-14→ Class A Common Shares (208,334 underlying)
Footnotes (1)
- [F1]Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal quarterly installments over a period of 36 months.